Neuropace Inc expected to post a loss of 30 cents a share - Earnings Preview

NeuroPace

09/08/2024 23:29

* Neuropace Inc  NPCE.OQ   NPCE.O  is expected to show a
rise in
quarterly revenue when it reports  results on August 13 for the
period ending June 30 2024
    * The Mountain View California-based  company is expected to
report a 10.8% increase in revenue to $18.297 million from
$16.51 million a year ago, according to the mean estimate from 6
analysts, based on LSEG data.
    * ​LSEG's mean analyst estimate for Neuropace Inc is for a
loss
of 30 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Neuropace
Inc is
$18.00​, above​ its last closing price of $6.98. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  -0.32       -0.32      -0.32     Met     0.5
 Sep. 30 2024  -0.30       -0.31      -0.23     Beat    27
 Sep. 30 2023  -0.41       -0.41      -0.28     Beat    31.7​
 Jun. 30 2023  -0.46       -0.46      -0.36     Beat    22.6
 ​​Jan.        -0.46       -0.46      -0.41     Beat    10.1
 1 0001                                                 
 Dec. 31 2022  -0.50       -0.49      -0.45     Beat    9.1​
 Sep. 30 2022  -0.52                  -0.48             8.9
 Jun. 30 2022  -0.44       -0.44      -0.52     Missed  -17.3
 This summary was machine generated August 9 at 22:29 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)